High-Shear Microfluidic Thrombosis Assay
NCT02422810 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2018-06-07
Summary
The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
Conditions
- Coagulation Defects, Other and Unspecified
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
Sharon Bergquist, MD · Emory University
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- United States
Study Locations
More Related Trials
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Warfarin Versus Aspirin Recurrent Stroke Study
NCT00027066 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
NCT00265408 ·Status: WITHDRAWN ·Phase: PHASE1
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
NCT06580223 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
NCT05247931 ·Status: UNKNOWN
-
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
NCT00688714 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Or Warfarin To Prevent Stroke
NCT00004728 ·Status: TERMINATED ·Phase: PHASE3
-
Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement
NCT00465218 ·Status: COMPLETED
-
Genotypic and Phenotypic Correlates of Resistance to Aspirin
NCT01361620 ·Status: COMPLETED ·Phase: NA
-
CV004-007 Thrombosis Chamber Study
NCT02439190 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin Resistance
NCT06740916 ·Status: RECRUITING ·Phase: PHASE3
-
Measurement of Platelet Dense Granule Release in Healthy Volunteers
NCT00942617 ·Status: WITHDRAWN ·Phase: NA
-
STAT-STatin and Aspirin in Trauma
NCT02901067 ·Status: TERMINATED ·Phase: PHASE2
-
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
NCT03787927 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Testing a Community Intervention to Increase Aspirin Use
NCT02607917 ·Status: COMPLETED ·Phase: NA
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
NCT02927249 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
NCT01023360 ·Status: UNKNOWN ·Phase: PHASE4
-
Recurrent Carotid Stenosis
NCT00000527 ·Status: COMPLETED ·Phase: PHASE2
-
In-Vivo Bleeding Volume Test for Platelet-Aspirin Interaction
NCT01047722 ·Status: UNKNOWN ·Phase: PHASE1
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Aspirin and Clopidogrel Resistance Study
NCT01039480 ·Status: COMPLETED
-
Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
NCT01668901 ·Status: WITHDRAWN ·Phase: PHASE4